Scarica l'app Stockscreener
0.57
2.55%
0.0142
Pre-mercato:
.57
Precedente Chiudi:
$0.5558
Aprire:
$0.5793
Volume 24 ore:
2.66M
Relative Volume:
0.23
Capitalizzazione di mercato:
$25.20M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-2.85
EPS:
-0.2
Flusso di cassa netto:
$10.81M
1 W Prestazione:
+25.58%
1M Prestazione:
+7.61%
6M Prestazione:
-67.24%
1 anno Prestazione:
-82.46%
Intervallo 1D:
$0.5545
$0.64
Intervallo di 1 settimana:
$0.42
$0.64
Portata 52W:
$0.2813
$3.445
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Confronta HBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.57 | 19.59M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
488.61 | 179.91B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
183.63 | 52.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.90 | 45.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.50 | 40.08B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
279.10 | 16.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Iniziato | Northland Capital | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Downgrade | Janney | Buy → Neutral |
| 2018-01-24 | Reiterato | Janney | Buy |
| 2018-01-23 | Reiterato | The Benchmark Company | Buy |
| 2016-11-17 | Iniziato | Singular Research | Buy |
| 2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
What makes Harvard Bioscience Inc. stock attractive to long term investorsSkyrocketing returns - jammulinksnews.com
What analysts say about Harvard Bioscience Inc. stockDouble or triple returns - Autocar Professional
What drives Harvard Bioscience Inc. stock priceHigh-performance investment picks - Autocar Professional
Does Harvard Bioscience (NASDAQ:HBIO) Have A Healthy Balance Sheet? - simplywall.st
Is Harvard Bioscience Inc. a good long term investmentExceptional gains - jammulinksnews.com
Harvard Bioscience Inc. Stock Analysis and ForecastExceptional growth trajectory - jammulinksnews.com
What makes Harvard Bioscience Inc. stock price move sharplyHigh Return Intraday Picks - Newser
Harvard Bioscience announces CEO succession plan - MSN
Harvard Bioscience stock holds Speculative Buy rating at Benchmark - Investing.com India
Harvard Bioscience stock holds Speculative Buy rating at Benchmark By Investing.com - Investing.com Canada
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire
Harvard Bioscience Announces CEO Succession Plan - TipRanks
Harvard Bioscience names John Duke as new CEO as Jim Green retires By Investing.com - Investing.com South Africa
Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com
Harvard Bioscience Announces John Duke as New President & CEO Following Jim Green's Retirement and Appoints Rob Gagnon and Seth Benson to Board of Directors - Quiver Quantitative
How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser
Harvard Bioscience (NASDAQ:HBIO) versus Electronic Sensor Technologies (OTCMKTS:ESNR) Financial Comparison - Defense World
Is Harvard Bioscience, Inc. technically bullish or bearish? - MarketsMojo
Harvard Bioscience falls out of Nasdaq compliance after board member resignation - Worcester Business Journal
Harvard Bioscience Faces Nasdaq Compliance Challenge - TipRanks
Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):